Chiang, Ying-Cheng <br/><br/>
Establishment of a New Ovarian Cancer Cell Line CA5171.  [electronic resource] 

 -  Reproductive sciences (Thousand Oaks, Calif.)  Jun 2015 
 - 725-34 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1933-7205 
<br/><br/><label>Standard No.: </label>10.1177/1933719114557893  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--pharmacology<br/>Biomarkers, Tumor--genetics<br/>Carcinoma, Ovarian Epithelial<br/>Cell Line, Tumor<br/>Cell Movement<br/>Cell Proliferation<br/>Cell Shape<br/>Cisplatin--pharmacology<br/>Class I Phosphatidylinositol 3-Kinases<br/>DNA Copy Number Variations<br/>Doxorubicin--pharmacology<br/>Drug Resistance, Neoplasm<br/>Epithelial-Mesenchymal Transition<br/>Female<br/>Gene Expression Regulation, Neoplastic<br/>Genetic Predisposition to Disease<br/>Humans<br/>Middle Aged<br/>Mutation<br/>Neoplasm Invasiveness<br/>Neoplasms, Glandular and Epithelial--drug therapy<br/>Ovarian Neoplasms--drug therapy<br/>PTEN Phosphohydrolase--genetics<br/>Paclitaxel--pharmacology<br/>Phenotype<br/>Phosphatidylinositol 3-Kinases--genetics<br/>Polymorphism, Single Nucleotide<br/>Tumor Suppressor Protein p53--genetics